Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 1
1966 2
1968 1
1969 2
1970 1
1971 4
1972 7
1973 6
1974 5
1975 2
1976 5
1977 4
1978 2
1979 5
1980 4
1981 8
1982 6
1983 8
1984 12
1985 10
1986 7
1987 10
1988 6
1989 6
1990 5
1991 9
1992 11
1993 9
1994 7
1995 4
1996 8
1997 8
1998 6
1999 8
2000 7
2001 5
2002 7
2003 8
2004 13
2005 25
2006 27
2007 27
2008 14
2009 22
2010 14
2011 16
2012 32
2013 18
2014 12
2015 17
2016 15
2017 19
2018 15
2019 8
2020 20
2021 25
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

537 results
Results by year
Filters applied: . Clear all
Page 1
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC. Woyach JA, et al. Among authors: ozer hg. N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1. N Engl J Med. 2018. PMID: 30501481 Free PMC article. Clinical Trial.
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.
Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS, Xue L, Li DH, Steggerda SM, Versele M, Dave SS, Zhang J, Yilmaz AS, Jaglowski SM, Blum KA, Lozanski A, Lozanski G, James DF, Barrientos JC, Lichter P, Stilgenbauer S, Buggy JJ, Chang BY, Johnson AJ, Byrd JC. Woyach JA, et al. Among authors: ozer hg. N Engl J Med. 2014 Jun 12;370(24):2286-94. doi: 10.1056/NEJMoa1400029. Epub 2014 May 28. N Engl J Med. 2014. PMID: 24869598 Free PMC article.
SV40-mediated immortalization.
Ozer HL. Ozer HL. Prog Mol Subcell Biol. 2000;24:121-53. doi: 10.1007/978-3-662-06227-2_6. Prog Mol Subcell Biol. 2000. PMID: 10547861 Review. No abstract available.
SV40-Mediated immortalization.
Jha KK, Banga S, Palejwala V, Ozer HL. Jha KK, et al. Among authors: ozer hl. Exp Cell Res. 1998 Nov 25;245(1):1-7. doi: 10.1006/excr.1998.4272. Exp Cell Res. 1998. PMID: 9828095 Review.
Pseudocoarctation.
Adaletli I, Kurugoglu S, Davutoglu V, Ozer H, Besirli K, Sayin AG. Adaletli I, et al. Among authors: ozer h. Can J Cardiol. 2007 Jun;23(8):675-6. doi: 10.1016/s0828-282x(07)70232-5. Can J Cardiol. 2007. PMID: 17593995 Free PMC article.
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia.
Walker JS, Hing ZA, Harrington B, Baumhardt J, Ozer HG, Lehman A, Giacopelli B, Beaver L, Williams K, Skinner JN, Cempre CB, Sun Q, Shacham S, Stromberg BR, Summers MK, Abruzzo LV, Rassenti L, Kipps TJ, Parikh S, Kay NE, Rogers KA, Woyach JA, Coppola V, Chook YM, Oakes C, Byrd JC, Lapalombella R. Walker JS, et al. Among authors: ozer hg. J Hematol Oncol. 2021 Jan 15;14(1):17. doi: 10.1186/s13045-021-01032-2. J Hematol Oncol. 2021. PMID: 33451349 Free PMC article.
Efficacy of convalescent plasma therapy in severe COVID-19 patients.
Akay Cizmecioglu H, Goktepe MH, Demircioglu S, Tekinalp A, Cizmecioglu A, Tuna AK, Ozer H. Akay Cizmecioglu H, et al. Among authors: ozer h. Transfus Apher Sci. 2021 Aug;60(4):103158. doi: 10.1016/j.transci.2021.103158. Epub 2021 May 8. Transfus Apher Sci. 2021. PMID: 33994106 Free PMC article.
Chest CT findings in RT-PCR positive asymptomatic COVID-19 patients.
Uysal E, Kilinçer A, Cebeci H, Özer H, Demir NA, Öztürk M, Koplay M. Uysal E, et al. Among authors: ozer h. Clin Imaging. 2021 Sep;77:37-42. doi: 10.1016/j.clinimag.2021.01.030. Epub 2021 Jan 30. Clin Imaging. 2021. PMID: 33640789 Free PMC article.
537 results